Tova Gur Arieh BREAKING
NEWS Why Mobilise-D matters – now more than ever! LATEST
VIDEO More Videos IEEE Transactions on Biomedical Engineering A Multifactorial Model of Multiple Sclerosis Gait and its Changes Across Different
Disability Levels Angelini L., Buckley, E. Bonci T., Radford A., Sharrack B., Paling D., Nair K., Mazzà C. Other publications LATEST
PUBLICATION SOCIAL MEDIA EMA Public Support for Mobilise-D: Follow-up BREAKING
NEWS Why Mobilise-D matters – now more than ever! LATEST
VIDEO More Videos IEEE Transactions on Biomedical Engineering A Multifactorial Model of Multiple Sclerosis Gait and its Changes Across Different
Disability Levels Angelini L., Buckley, E. Bonci T., Radford A., Sharrack B., Paling D., Nair K., Mazzà C. Other publications LATEST
PUBLICATION SOCIAL MEDIA When life gives you lemons, make Lemon Drizzle cake! BREAKING
NEWS Why Mobilise-D matters – now more than ever! LATEST
VIDEO More Videos IEEE Transactions on Biomedical Engineering A Multifactorial Model of Multiple Sclerosis Gait and its Changes Across Different
Disability Levels Angelini L., Buckley, E. Bonci T., Radford A., Sharrack B., Paling D., Nair K., Mazzà C. Other publications LATEST
PUBLICATION SOCIAL MEDIA Mobilise-D and IDEA-FAST announce the creation of the Digital Health Catalyst (DHC) BREAKING
NEWS Why Mobilise-D matters – now more than ever! LATEST
VIDEO More Videos IEEE Transactions on Biomedical Engineering A Multifactorial Model of Multiple Sclerosis Gait and its Changes Across Different
Disability Levels Angelini L., Buckley, E. Bonci T., Radford A., Sharrack B., Paling D., Nair K., Mazzà C. Other publications LATEST
PUBLICATION SOCIAL MEDIA In the spotlight: Abolfazl Soltani’s Public PhD defense, Friday, Dec 11 BREAKING
NEWS Why Mobilise-D matters – now more than ever! LATEST
VIDEO More Videos IEEE Transactions on Biomedical Engineering A Multifactorial Model of Multiple Sclerosis Gait and its Changes Across Different
Disability Levels Angelini L., Buckley, E. Bonci T., Radford A., Sharrack B., Paling D., Nair K., Mazzà C. Other publications LATEST
PUBLICATION SOCIAL MEDIA Webinar: Beatrix Vereijken and Valdo Arnera to present Mobilise-D on eClinical Forum BREAKING
NEWS Why Mobilise-D matters – now more than ever! LATEST
VIDEO More Videos IEEE Transactions on Biomedical Engineering A Multifactorial Model of Multiple Sclerosis Gait and its Changes Across Different
Disability Levels Angelini L., Buckley, E. Bonci T., Radford A., Sharrack B., Paling D., Nair K., Mazzà C. Other publications LATEST
PUBLICATION SOCIAL MEDIA

Connecting digital mobility assessment to clinical outcomes
for regulatory and clinical endorsement

What?

What?

Mobilise-D is a 5-year, IMI-funded project that will produce validated and accepted digital mobility outcomes to monitor daily life gait of people with different mobility problems, with the goal to improve follow-up and personalized care.

About Us

How?

How?

Mobilise-D will perform a technical and clinical validation of a sensor-algorithm pair in different patient groups. We maintain close dialogue with the European Medicines Agency (EMA) to facilitate the process of regulatory approval.

About Us

Who?

Who?

The Mobilise-D consortium consists of 34 partners from Europe and the USA. Over 200 professionals with technical, clinical, and regulatory expertise will work together to bring digital mobility outcomes to the clinic.                                                                  

About Us

Mobility – how well we walk – is an important marker of health; a slow walking speed is associated with greater mortality, morbidity, cognitive decline, dementia, and fall risk. As the population ages, the number of people experiencing mobility challenges is expected to rise. However, accurately assessing people’s mobility, especially in the real daily life world, is far from easy.

Mobilise-D will develop a comprehensive system to monitor and evaluate people’s gait based on digital technologies, including sensors worn on the body. The project focuses on conditions which often affect mobility, namely chronic obstructive pulmonary disease, Parkinson’s disease, multiple sclerosis, hip fracture recovery, and congestive heart failure.

The Mobilise-D results will help to improve the accurate assessment of daily life mobility in clinical trials and patient treatment, thereby contributing to improved and more personalised care.

Patient Groups

Mobilise-D will focus on five different patient groups that together represent respiratory problems (chronic obstructive pulmonary disease – COPD), neurodegenerative conditions (Parkinson’s disease – PD), neuroinflammatory problems (multiple sclerosis – MS), osteoporosis and sarcopenia (hip fracture recovery/proximal femoral fracture – PFF), and cardiac pathology (congestive heart failure – CHF).

These patient groups cover a range of walking speed, mobility challenges, and potential events that we care about, such as improving versus worsening of function, falls, hospitalisation, nursing home admission, and death. Furthermore, these patient groups will be followed at 12 different sites across Europe, ensuring a good geographical representation and covering a diverse representation of health care organisation, such as in- versus outpatient care, as well as public versus private health services.

Read More

Twitter Feed

Mobilise-D @Mobilise_D

Do you need some reading material for lazy summer days? 📗🦥⛱️🍹☀️

Check out one of our #InTheSpotlight Episodes!😎👇

🔗 https://t.co/aoSrgzSm4V

#MobiliseD #HealthTech #mobility @IMI_JU @EFPIA
View on Twitter
4
5
Mobilise-D @Mobilise_D

📢UPCOMING VIRTUAL WORKSHOP📢
One week until the workshop on " #RealWorld #DigitalMobilityAssessment" at the @IEEEembs Conference! It is organized by three Mobilisers; A.Cereatti, @sil_bam, and @kluger_felix🤩
📅July 27
🕐13:00-15:35 CEST
🔗 https://t.co/GZnN0J5jmV
@IMI_JU @EFPIA
View on Twitter
5
12

Latest News

EMA Public Support for Mobilise-D: Follow-up

In the first year of Mobilise-D, we asked the European Medicines Agency (EMA) for Qualification Advice regarding Digital Mobility Outcomes (DMOs). EMA published their first letter of support in April 2020 that publicly endorsed our initial stage in the wider objective of the Mobilise-D consortium to pursue the qualification of Digital Mobility Outcomes (DMOs) as…

Read more

Upcoming Events

No event found!
Sign up for our Newsletter!